DK0526537T3 - 5-Benzylbarbituratderivater - Google Patents

5-Benzylbarbituratderivater

Info

Publication number
DK0526537T3
DK0526537T3 DK91908585.2T DK91908585T DK0526537T3 DK 0526537 T3 DK0526537 T3 DK 0526537T3 DK 91908585 T DK91908585 T DK 91908585T DK 0526537 T3 DK0526537 T3 DK 0526537T3
Authority
DK
Denmark
Prior art keywords
benzyl barbiturate
toxicity
barbiturate derivatives
compounds
benzyl
Prior art date
Application number
DK91908585.2T
Other languages
English (en)
Inventor
Fardos N M Naguib
Kouni Mahmoud H El
Raymond P Panzica
Sungman Cha
Original Assignee
Univ Brown Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Brown Res Found filed Critical Univ Brown Res Found
Application granted granted Critical
Publication of DK0526537T3 publication Critical patent/DK0526537T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C07D239/62—Barbituric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK91908585.2T 1990-04-12 1991-04-12 5-Benzylbarbituratderivater DK0526537T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/508,363 US5141943A (en) 1990-04-12 1990-04-12 5-benzyl barbiturate derivatives

Publications (1)

Publication Number Publication Date
DK0526537T3 true DK0526537T3 (da) 1995-10-02

Family

ID=24022452

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91908585.2T DK0526537T3 (da) 1990-04-12 1991-04-12 5-Benzylbarbituratderivater

Country Status (10)

Country Link
US (1) US5141943A (da)
EP (1) EP0526537B1 (da)
JP (1) JP3001972B2 (da)
AT (1) ATE124936T1 (da)
AU (1) AU7776891A (da)
CA (1) CA2080343C (da)
DE (1) DE69111232T2 (da)
DK (1) DK0526537T3 (da)
ES (1) ES2077850T3 (da)
WO (1) WO1991016315A1 (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776838B1 (en) 1987-10-28 2010-08-17 Wellstat Therapeutics Corporation Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
US5968914A (en) * 1987-10-28 1999-10-19 Pro-Neuron, Inc. Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
US5691320A (en) * 1987-10-28 1997-11-25 Pro-Neuron, Inc. Acylated pyrimidine nucleosides for treatment of systemic inflammation and inflammatory hepatitis
US5736531A (en) 1987-10-28 1998-04-07 Pro-Neuron, Inc. Compositions of chemotherapeutic agent or antiviral agent with acylated pyrimidine nucleosides
US5470838A (en) * 1987-10-28 1995-11-28 Pro-Neuron, Inc. Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine
GB9214720D0 (en) * 1992-07-10 1992-08-19 Wellcome Found Enzyme inhibitors
JPH08503699A (ja) * 1992-12-08 1996-04-23 プロ − ニューロン，インコーポレーテッド 全身性炎症と炎症性肝炎の治療のためのピリミジンヌクレオチド前駆体
WO1994015605A1 (en) * 1993-01-14 1994-07-21 Cell Therapeutics, Inc. Acetal or ketal substituted therapeutic compounds
US5567689A (en) * 1993-08-13 1996-10-22 The Uab Research Foundation Methods for increasing uridine levels with L-nucleosides
US5476855A (en) * 1993-11-02 1995-12-19 Mahmoud H. el Kouni Enzyme inhibitors, their synthesis and methods for use
EP0748316B1 (en) * 1994-02-28 2002-05-08 Sunkyong Industries Co., Ltd. Pyrimidine acyclonucleoside derivatives
EP0768883A4 (en) * 1994-07-01 2004-09-15 Wellstat Therapeutics Corp PYRIMIDINE NUCLEOTIDE PRECURSORS FOR THE TREATMENT OF SYSTEMIC INFLAMMATION AND INFLAMMATORY HEPATITIS
US7198190B2 (en) * 1997-03-12 2007-04-03 Dodge Juhan Identification device having reusable transponder
JPH11279157A (ja) * 1998-03-27 1999-10-12 Hoechst Marion Roussel Kk バルビツール酸誘導体およびそれらからなる骨・軟骨疾患予防・治療薬
CA2333537A1 (en) * 1998-05-26 1999-12-02 Rimma Iliinichna Ashkinazi N-substituted derivatives of 5-oxyiminobarbituric acid
US8314064B2 (en) * 1998-07-31 2012-11-20 Massachusetts Institute Of Technology Uridine administration stimulates membrane production
US20070004670A1 (en) * 1998-07-31 2007-01-04 Richard Wurtman Compositions containing citicoline, and methods of use thereof
US8143234B2 (en) * 1998-07-31 2012-03-27 Massachusetts Institute Of Technology Uridine administration improves phosphatide synthesis, synaptic transmission and cognitive function
US20060069061A1 (en) * 1998-07-31 2006-03-30 Dick Wurtman Compositions containing uridine and choline, and methods utilizing same
EP2145627B1 (en) 1998-07-31 2014-04-16 Massachusetts Institute Of Technology Use of uridine in combination with choline for the treatment of mood and emotional disorders
US8518882B2 (en) * 1998-07-31 2013-08-27 Massachusetts Institute Of Technology Methods and compositions for ameliorating or inhibiting decline in memory or intelligence or improving same
GB0013655D0 (en) * 2000-06-05 2000-07-26 Prolifix Ltd Therapeutic compounds
DE10110355A1 (de) * 2001-03-03 2002-09-12 Ulrich Walker Bekämpfung von Nebenwirkungen
WO2009059306A1 (en) * 2007-11-02 2009-05-07 Massachusetts Institute Of Technology Uridine dietary supplementation compliance methods and use thereof
US7998967B2 (en) 2008-03-03 2011-08-16 Tosk, Incorporated Methotrexate adjuvants to reduce toxicity and methods for using the same
RU2581467C1 (ru) * 2015-04-06 2016-04-20 Федеральное государственное бюджетное учреждение науки "Институт токсикологии Федерального медико-биологического агентства" Антидот окиси углерода
DE102016011954A1 (de) * 2016-10-07 2018-04-12 Merck Patent Gmbh Barbitursäurederivate als Selbstbräunungssubstanzen
EP3774804A1 (en) 2018-03-26 2021-02-17 Novartis AG N-(3-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)benzamide derivatives
US11446303B2 (en) 2019-06-21 2022-09-20 Tosk, Inc. Uridine phosphorylase (UPase) inhibitors for treatment of liver conditions
JP7785663B2 (ja) * 2019-09-16 2025-12-15 ノバルティス アーゲー 二機能性分解誘導薬及びそれらの使用方法
WO2024200612A1 (en) * 2023-03-30 2024-10-03 Université de Lausanne Inhibitors of uridine catabolism and/or transport for therapy

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3282921A (en) * 1964-06-04 1966-11-01 Syntex Corp Halo-deoxynucleosides and processes for the preparation thereof
US3464990A (en) * 1967-02-27 1969-09-02 Hoffmann La Roche Barbituric acid derivatives substituted in the five position
US3755295A (en) * 1969-10-24 1973-08-28 Syntex Corp 1-(2-amino-2-deoxy-{62 -d-ribofuranosyl) pyrimidines and derivatives thereof
US3775397A (en) * 1969-11-12 1973-11-27 Akad Wissenschaften Ddr Novel cytostatic 2',3'-dideoxy-3'-fluoropyrimidine-nucleosides
US3687931A (en) * 1970-03-19 1972-08-29 Syntex Corp Halogenated purine and pyrimidine nucleosides and process therefor
US3817982A (en) * 1971-12-29 1974-06-18 Syntex Inc 2{40 ,3{40 -unsaturated nucleosides and method of making
DE2627076A1 (de) * 1976-06-16 1977-12-29 Max Planck Gesellschaft Mittel zur inhibierung des zellwachstums
US4071680A (en) * 1976-12-20 1978-01-31 Hoffmann-La Roche Inc. 5'-Deoxy-5-fluoropyrimidine nucleosides
US4093715A (en) * 1977-04-28 1978-06-06 Research Corporation 5-Iodo-5'-amino-2',5'-dideoxycytidine and the pharmaceutically acceptable salts thereof
US4128639A (en) * 1977-12-14 1978-12-05 Research Corporation Nitrosourea analogs of thymidine
US4210638A (en) * 1978-03-17 1980-07-01 Pcr, Inc. Antiviral composition and method of treating virus diseases
US4230698A (en) * 1978-05-12 1980-10-28 Research Corporation 2-Substituted arabinofuranosyl nucleosides and nucleotides
US4604382A (en) * 1983-01-17 1986-08-05 Research Corporation 3'-amino-2',3'-dideoxycytidine and the pharmacologically acceptable salts thereof
US4681933A (en) * 1986-05-01 1987-07-21 University Of Georgia Research Foundation, Inc. 2',3'-dideoxy-5-substituted uridines and related compounds as antiviral agents

Also Published As

Publication number Publication date
DE69111232D1 (de) 1995-08-17
EP0526537B1 (en) 1995-07-12
US5141943A (en) 1992-08-25
CA2080343A1 (en) 1991-10-13
EP0526537A1 (en) 1993-02-10
AU7776891A (en) 1991-11-11
JPH05506240A (ja) 1993-09-16
ES2077850T3 (es) 1995-12-01
WO1991016315A1 (en) 1991-10-31
DE69111232T2 (de) 1995-12-21
ATE124936T1 (de) 1995-07-15
JP3001972B2 (ja) 2000-01-24
CA2080343C (en) 2001-10-23

Similar Documents

Publication Publication Date Title
DK0526537T3 (da) 5-Benzylbarbituratderivater
ATE225341T1 (de) In 6-position durch thio substituierte paclitaxele
MX9303711A (es) Nucleosidos de pirimida sustituida que tienen actividad anti-tumoral y anti-viral y composicion farmaceutica que los contiene.
DK0465297T3 (da) 9-Purinylphosphonsyre-derivater
DK0545966T3 (da) Phospholipidderivater af nucleosider, deres fremstilling samt deres anvendelse som anti-virale lægemidler
FI952248L (fi) Kasvainvastaisia koostumuksia, jotka sisältävät taksaanijohdannaisia
ES2185378T3 (es) Quimioterapia de cancer con acetildinalina en combinacion con gemcitabina, capecitabina o cisplatina.
PT100199A (pt) Combinacao antiviral de nucleosidos e processo para a sua preparacao
BR9914221B1 (pt) Derivados de glicopeptídeos e composições farmacêuticas contendo os mesmos
DZ1270A1 (fr) Dérivés de fluorocytidine.
PT1066269E (pt) Derivados de 1,3,5-triazina trissubstrituidos para o tratamento de infeccoes por hiv
ATE137242T1 (de) Kovalente-ther lipidnukleosid-konjugate
ATE254132T1 (de) Antivirale pyrimidin nucleoside derivate
ES2074719T3 (es) Derivados de nucleosido de pirimidina.
ATE205850T1 (de) Behandlung der toxischen wirkung von chemotherapeutischen und antiviralen wirkstoffen mit acylierten pyrimidinnukleosiden
NL300247I2 (nl) 2-Halogeen-9-(2-desoxy-2-fluor-bêta-D-arabinofuranosyl)-adeninenucleosiderivaten.
FI942188A7 (fi) Triatsiinijohdannaisia kasvaintenvastaisen aktiivisuuden tehostamiseks i
NO985307D0 (no) Distamycinderivater, fremgangsmÕte for deres fremstilling, og deres anvendelse som antitumor- og antivirale midler
NO971142D0 (no) Bis-(2-halogenetyl)aminofenylsubstituerte distamycinderivater som antitumor- og antivirale midler
ES2104917T3 (es) Bis-naftalimidas que contienen engarces amido y tioamido como agentes anticancerosos.
ES2062724T3 (es) Utilizacion de derivados de la triazina y de la pirimidina para la obtencion de medicamentos que combaten la resistencia a los agentes anticancerosos y antimalaricos.
NO913659L (no) Hemming av hiv ved anvendelse av synergistiske kombinasjoner av nukleosidderivater.
FI912486A7 (fi) 6-substituoituja purinyylipiperatsiinijohdannaisia
FI912513L (fi) Syntes av nukleotid- och nukleosidderivat.
FI956246L (fi) Hiili-asykliset nukleosidijohdannaiset antiviraalisina ja antineoplastisina aineina